Balance Sheet
Cash Flow Statement
AmortizationChange in TaxesNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics (PRQR) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to $19384.7.

  • ProQR Therapeutics' Cash from Investing Activities rose 11020.79% to $19384.7 in Q4 2022 from the same period last year, while for Dec 2022 it was -$748991.3, marking a year-over-year decrease of 5055.22%. This contributed to the annual value of -$4.4 million for FY2024, which is 19526.27% down from last year.
  • As of Q4 2022, ProQR Therapeutics' Cash from Investing Activities stood at $19384.7, which was up 11020.79% from -$248035.5 recorded in Q3 2022.
  • ProQR Therapeutics' Cash from Investing Activities' 5-year high stood at $19384.7 during Q4 2022, with a 5-year trough of -$273850.4 in Q1 2022.